CPX-351 a promising candidate for secondary acute myeloid leukaemia in seniors
CPX-351, a liposomal encapsulation of cytarabine and daunorubicin, is safe and effective in elderly patients with secondary acute myeloid leukaemia, leading to remission and improving patient response to allogeneic stem cell transplantation, a recent study has found.